CW McMillan

512 total citations
15 papers, 403 citations indexed

About

CW McMillan is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, CW McMillan has authored 15 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 5 papers in Genetics and 2 papers in Pathology and Forensic Medicine. Recurrent topics in CW McMillan's work include Hemophilia Treatment and Research (8 papers), Platelet Disorders and Treatments (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). CW McMillan is often cited by papers focused on Hemophilia Treatment and Research (8 papers), Platelet Disorders and Treatments (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). CW McMillan collaborates with scholars based in United States. CW McMillan's co-authors include Jack Lazerson, LW Hoyer, HC Kim, GC White, LM Aledort, HR Roberts, MV Ragni, E.W. Lovrien, C. Thomas Kisker and Ronald Jaffe and has published in prestigious journals such as Blood, American Journal of Physiology-Legacy Content and PubMed.

In The Last Decade

CW McMillan

15 papers receiving 378 citations

Peers

CW McMillan

HEMAT

GENET

MB

HEPAT

ONCOL

H. G. J. Brummelhuis Netherlands

P. H. Renton Nigeria

Bach‐Nga Pham France

Talley Parker United States

Klein Hg United States

Vincenzo Mettivier Italy

N Chkoff France

Nahıde Konuk Türkiye

Duni Sawadogo Ivory Coast

Étienne Paubelle France

H. G. J. Brummelhuis Netherlands

CW McMillan

166 ×0.6

HEMAT

57 ×0.6

GENET

74 ×1.2

MB

46 ×0.9

HEPAT

8 ×0.2

ONCOL

Citations per year, relative to CW McMillan CW McMillan (= 1×) peers H. G. J. Brummelhuis

Countries citing papers authored by CW McMillan

Since Specialization

Citations

This map shows the geographic impact of CW McMillan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CW McMillan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CW McMillan more than expected).

Fields of papers citing papers by CW McMillan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by CW McMillan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CW McMillan. The network helps show where CW McMillan may publish in the future.

Co-authorship network of co-authors of CW McMillan

This figure shows the co-authorship network connecting the top 25 collaborators of CW McMillan. A scholar is included among the top collaborators of CW McMillan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with CW McMillan. CW McMillan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Ragni, MV, Ronald Jaffe, CW McMillan, et al.. (1993). Acquired immunodeficiency syndrome-associated non-Hodgkin's lymphomas and other malignancies in patients with hemophilia. Blood. 81(7). 1889–1897. 58 indexed citations

2.

Ragni, MV, et al.. (1993). Acquired immunodeficiency syndrome-associated non-Hodgkin's lymphomas and other malignancies in patients with hemophilia. Blood. 81(7). 1889–1897. 4 indexed citations

3.

Kim, HC, et al.. (1992). Purified factor IX using monoclonal immunoaffinity technique: clinical trials in hemophilia B and comparison to prothrombin complex concentrates. Blood. 79(3). 568–575. 2 indexed citations

4.

Kim, HC, et al.. (1992). Purified factor IX using monoclonal immunoaffinity technique: clinical trials in hemophilia B and comparison to prothrombin complex concentrates. Blood. 79(3). 568–575. 70 indexed citations

5.

McMillan, CW, et al.. (1988). The natural history of factor VIII:C inhibitors in patients with hemophilia A: a national cooperative study. II. Observations on the initial development of factor VIII:C inhibitors. Blood. 71(2). 344–348. 125 indexed citations

6.

McMillan, CW, et al.. (1988). The natural history of factor VIII:C inhibitors in patients with hemophilia A: a national cooperative study. II. Observations on the initial development of factor VIII:C inhibitors. Blood. 71(2). 344–348. 4 indexed citations

7.

Eyster, M. Elaine, PM Catalano, CW McMillan, et al.. (1985). Long-term follow-up of hemophiliacs with lymphocytopenia or thrombocytopenia. Blood. 66(6). 1317–1320. 30 indexed citations

8.

Eyster, M. Elaine, PM Catalano, CW McMillan, et al.. (1985). Long-term follow-up of hemophiliacs with lymphocytopenia or thrombocytopenia. Blood. 66(6). 1317–1320. 23 indexed citations

9.

McMillan, CW. (1984). Clinical patterns of hemophilic patients who develop inhibitors.. PubMed. 150. 31–44. 6 indexed citations

10.

McMillan, CW, et al.. (1982). Chronic hepatitis in patients with hemophilia A: histologic studies in patients with intermittently abnormal liver function tests.. Blood. 60(6). 1259–62. 29 indexed citations

11.

McMillan, CW, et al.. (1979). Fatal splenic sequestration crisis.. PubMed. 106(9). 679–80. 2 indexed citations

12.

McMillan, CW, et al.. (1979). Congenital deficiency of blood clotting factors II, VII, IX, and X. Blood. 53(4). 776–787. 4 indexed citations

13.

McMillan, CW, et al.. (1979). Congenital deficiency of blood clotting factors II, VII, IX, and X. Blood. 53(4). 776–787. 44 indexed citations

14.

McMillan, CW, et al.. (1975). Guanazole (NSC-1895) in the treatment of childhood leukemia.. PubMed. 58(5 Pt 1). 715–7. 1 indexed citations

15.

McMillan, CW, et al.. (1968). Plasma factor 8 activity in newborn dogs. American Journal of Physiology-Legacy Content. 214(2). 395–399. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact